by William Jester | Jul 13, 2023 | Covid, News
Please read Dr. Singla’s article in PLOS ONE titled, “A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection.” A novel coronavirus was first reported in December 2019 and declared an international...
by William Jester | Jul 11, 2023 | Community, News
A Rutgers-led consortium has been awarded $18 million to help tobacco regulators by providing the U.S. Food and Drug Administration (FDA) with real-time data on tobacco and nicotine marketing, products and consumer behaviors. “Nothing like this has ever been attempted...
by William Jester | Jul 11, 2023 | News
Please read Dr. Barrett’s article in the Journal of Allergy and Clinical Immunology titled, “Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth.”...
by William Jester | Jul 11, 2023 | Community, News
The majority of individuals with multiple sclerosis (MS) treat the chronic and progressive neurological disorder with oral medications, likely because of many factors, including convenience, consumer advertising and approval by health insurers, according to Rutgers...
by William Jester | Jul 10, 2023 | Community, News
The widely-available drug fentanyl, already the number one killer of Americans under 50, could be weaponized and used for terroristic mass poisoning, according to health experts at Rutgers and other institutions. “Before fentanyl, the only viable mass poisons were...
